학술논문

A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients
Document Type
Journal
Source
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM; APR 2006, 91 4, p1470-p1476, 7p.
Subject
Language
English
ISSN
0021972X